Why is Vivimed Labs Ltd ?
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 12.57 times
- The company has been able to generate a Return on Equity (avg) of 1.75% signifying low profitability per unit of shareholders funds
2
Negative results in Jun 23
- PAT(HY) At Rs -281.57 cr has Grown at -34.93 %
- DEBT-EQUITY RATIO(HY) Highest at 9.60 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.44 times
3
Risky - No result in last 6 months
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 0.00%, its profits have fallen by -267.9%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
-32.46%
EBIT Growth (5y)
-213.27%
EBIT to Interest (avg)
-1.77
Debt to EBITDA (avg)
9.69
Net Debt to Equity (avg)
9.51
Sales to Capital Employed (avg)
0.64
Tax Ratio
0.64%
Dividend Payout Ratio
0
Pledged Shares
37.06%
Institutional Holding
1.76%
ROCE (avg)
-8.47%
ROE (avg)
1.75%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
4.79
EV to EBIT
-1.96
EV to EBITDA
-3.15
EV to Capital Employed
1.36
EV to Sales
3.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-71.39%
ROE (Latest)
-833.41%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Loading Valuation Snapshot...
Here's what is working for Vivimed Labs.
Operating Profit (PBDIT) - Quarterly
Highest at Rs -0.33 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at -0.93%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs -15.69 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs -15.58 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs -1.88
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Vivimed Labs.
Net Sales - Quarterly
At Rs 35.35 cr has Fallen at -24.4 %
over average Net Sales of the previous four quarters of Rs 46.78 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Interest - Quarterly
At Rs 10.66 cr has Grown at 25.12 %
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debt-Equity Ratio - Half Yearly
Highest at 9.60 times and Grown
each half year in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 2.44 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Net Sales - Quarterly
Lowest at Rs 35.35 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Interest - Quarterly
Highest at Rs 10.66 cr
in the last five quarters and Increased by 25.12 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)






